Immunodiagnostic Systems Hldgs PLC

?

08/01/2014

Immunodiagnostic Systems Holdings plc (the "Company")

Additional Listing 

Application has today been made to AIM for admission of 35,000 new Ordinary Shares of 2 pence each in theCompany("Shares").  These Shares, which will rank pari passu in all respects with the existing shares in issue, have today been allotted pursuant to the exercise of options under the Company's Unapproved Share Option Scheme.

Admission is expected to become effective on 14 January 2014.  Following admission to trading of the Shares, the Company will have 29,161,915 Ordinary Shares of 2 pence each in issue.

For further information:

Immunodiagnostic Systems Holdings plc

Tel : +44 (0)191 5190660

Patrik Dahlen,ChiefExecutiveOfficer


Chris Yates, Finance Director




Peel Hunt LLP

Tel : +44 (0)207 418 8900

James Steel


Oliver Jackson






FTI Consulting

Tel : +44 (0)207 831 3113

Ben Atwell


Simon Conway


Mo Noonan


About Immunodiagnostic Systems Holdings PLC

The Group operates in the in-vitro diagnostics ("IVD") market by designing, manufacturing and selling immunoassay kits as well as its automated analyser, the IDS-iSYS System. The IDS product range is used to measure or detect particular substances within a sample, thus aiding the diagnosis or monitoring of a disease or providing information for research studies.


This information is provided by RNS
The company news service from the London Stock Exchange
ENDLISUGUMCGUPCGPR
distributed by